No ethnic difference between Caucasian and Japanese hepatic samples in the expression frequency of CYP3A5 and CYP3A7 proteins

Biochemical Pharmacology

Volumn 57, Issue 8, 1999, Pages 935-939

  Tateishi, Tomonori ^a   Watanabe, Minoru ^a   Moriya, Hitonobu ^a   Yamaguchi, Susumu ^a   Sato, Tetsuo ^b   Kobayashi, Shinichi ^a  

^a ST MARIANNA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Biomedical Research Institute   (Japan)

Author keywords

Caucasian; CYP3A4; CYP3A5; CYP3A7; Ethnic difference; Hepatic microsomes; Japanese; Nifedipine oxidation activity

Indexed keywords

CYTOCHROME P450 ISOENZYME; NIFEDIPINE;

ADULT; AGED; ARTICLE; CAUCASIAN; DRUG OXIDATION; ETHNIC DIFFERENCE; FEMALE; HUMAN; HUMAN TISSUE; JAPAN; LIVER MICROSOME; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADOLESCENT; ADULT; AGED; ARYL HYDROCARBON HYDROXYLASES; ASIAN CONTINENTAL ANCESTRY GROUP; CYTOCHROME P-450 ENZYME SYSTEM; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENE EXPRESSION; GENE FREQUENCY; HUMANS; JAPAN; MALE; MICROSOMES, LIVER; MIDDLE AGED; NIFEDIPINE; OXIDATION-REDUCTION;

EID: 0033561681     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(98)00375-X     Document Type: Article

References (27)

1. Wood A.J.J., Zhou H.H. Ethnic difference in drug disposition and responsiveness. Clin Pharmacokinet. 20:1991;350-373.
2. May D.G. Genetic differences in drug disposition. J Clin Pharmacol. 34:1994;881-897.
3. Guengerich F.P. Human cytochrome P450 enzymes. Oritiz de Montellano P.R., Cytochrome P450. 2nd Edn :1995;473-535 Plenum Press, New York.
4. Eichelbaum M., Gross A.S. The genetic polymorphism of debrisoquine/sparteine metabolism - Clinical aspects. Pharmacol Ther. 46:1990;377-394.
5. Wilkinson G.R., Guengerich F.P., Branch R.A. Genetic polymorphism of S-mephenytoin hydroxylation. Pharmacol Ther. 36:1989;773-780.
6. Daly A.K., Brockmöller J., Broly F., Eichelbaum M., Evans W.E., Gonzalez F.J., Huang J.D., Idle J.R., Ingelman-Sundberg M., Ishizaki T., Meyer U.A., Nebert D.W., Steen V.M., Wolf C.R., Zanger U.M. Nomenclature for human CYP2D6 alleles. Pharmacogenetics. 6:1996;193-201.
7. Schellens J.H.M., Soons P.A., Breimer D.D. Lack of bimodality in nifedipine plasma kinetics in a large population of healthy subjects. Biochem Pharmacol. 37:1988;2507-2510.
8. Ahsan C.H., Renwick A.G., Macklin B., Challenor V.F., Waller D.G., George C.F. Ethnic differences in the pharmacokinetics of oral nifedipine. Br J Clin Pharmacol. 31:1991;399-403.
9. Sowunmi A., Rashid T.J. Akinyinka OO and Renwick AG, Ethnic differences in nifedipine kinetics: Comparisons between Nigerians, Caucasians and South Asians. Br J Clin Pharmacol. 40:1995;489-493.
10. Shimada T., Yamazaki H., Mimura M., Inui Y., Guengerich F.P. Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals Studies with liver microsomes of 30 Japanese and 30 Caucasians . J Pharmacol Exp Ther. 270:1994;414-423.
11. Kitada M., Kamataki T., Itahashi K., Rikihisa T., Kato R., Kanakubo Y. Purification and properties of cytochrome P-450 from homogenates of human fetal liver. Arch Biochem Biophys. 241:1985;275-280.
12. Schuetz J.D., Beach D.L., Guzelian P.S. Selective expression of cytochrome P450 CYP3A mRNAs in embryonic and adult human liver. Pharmacogenetics. 4:1994;11-20.
13. Aoyama T., Yamano S., Waxman D.J., Lapenson D.P., Meyer U.A., Fisher V., Tyndale R., Inaba T., Kalow W., Gelboin H.V., Gonzalez F.J. Cytochrome P-450 hPCN3, a novel cytochrome P-450 IIIA gene product that is differentially expressed in adult human liver. cDNA and deduced amino acid sequence and distinct specificities of cDNA-expressed hPCN1 and hPCN3 for the metabolism of steroid hormones and cyclosporine. J Biol Chem. 264:1989;10388-10395.
14. Wrighton S.A., Ring B.J., Watkins P.B., Vandenbranden M. Identification of a polymorphically expressed member of the human cytochrome P-450III family. Mol Pharmacol. 36:1989;97-105.
15. Wrighton S.A., Brian W.R., Sari M.-A., Iwasaki M., Guengerich F.P., Raucy J.L., Molowa D.T., Vandenbranden M. Studies on the expression and metabolic capabilities of human liver cytochrome P450IIIA5 (HLp3). Mol Pharmacol. 38:1990;207-213.
16. Kitada M., Kamataki T., Itahashi K., Rikihisa T., Kanakubo Y. Significance of cytochrome P-450 (P-450 HFLa) of human fetal livers in the steroid and drug oxidations. Biochem Pharmacol. 36:1987;453-456.
17. Kitada M., Kamataki T., Itahashi K., Rikihisa T., Kanakubo Y. P-450 HFLa, a form of cytochrome P-450 purified from human fetal livers, is the 16α-hydroxylase of dehydroepiandrosterone 3-sulfate. J Biol Chem. 262:1987;13534-13537.
18. Gillam E.M.J., Wunsch R.M., Ueng Y.-F., Shimada T., Reilly P.E.B., Kamataki T., Guengerich F.P. Expression of cytochrome P450 3A7 in Escherichia coli: Effects of 5′ modification and catalytic characterization of recombinant enzyme expressed in bicistronic format with NADPH-cytochrome P450 reductase. Arch Biochem Biophys. 346:1997;81-90.
19. Nakura H., Itoh S., Kusano H., Ishizone H., Imaoka S., Funae Y., Yokoi T., Kamataki T. Decrease in the content of cytochrome P450IIE by fasting in liver microsomes of house musk shrew (Suncus murinus). Biochem Pharmacol. 43:1992;1907-1910.
20. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with the Folin phenol reagent. J Biol Chem. 193:1951;265-275.
21. Guengerich F.P., Martin M.V., Beaune P.H., Kremers P., Wolff T., Waxman D.J. Characterization of rat and human liver microsomal cytochrome P-450 forms involved in nifedipine oxidation, a prototype for genetic polymorphism inoxidative drug metabolism. J Biol Chem. 261:1986;391-407.
22. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 227:1970;680-685.
23. Guengerich F.P., Wang P., Davidson N.K. Estimation of isozymes of microsomal cytochrome P-450 in rats, rabbits and humans using immunochemical staining coupled with SDS-polyacrylamide gel electrophoresis. Biochemistry. 21:1982;1698-1706.
24. Li Y., Yokoi T., Kitamura R., Sasaki M., Gunji M., Katsuki M., Kamataki T. Establishment of transgenic mice carring human fetus-specific CYP3A7. Arch Biochem Biophys. 329:1996;235-240.
25. Guengerich F.P., Turvy C.G. Comparison of levels of several human microsomal cytochrome P-450 enzymes and epoxide hydrolase in normal and disease states using immunochemical analysis of surgical liver samples. J Pharmacol Exp Ther. 256:1991;1189-1194.
26. Lacroix D., Sonnier M., Moncion A., Cheron G., Cresteil T. Expression of CYP3A in the human liver: Evidence that the shift between CYP3A7 and CYP3A4 occurs immediately after birth. Eur J Biochem. 247:1997;625-634.
27. Kitada M., Tsukidate K., Takeuchi J., Taneda M., Komori M., Ohi H., Itahashi K., Kamataki T. Immunochemical studies for the presence of P-450HFLa, a form of cytochrome P-450 in human fetal livers, in human hepatocellular carcinoma cells. J Pharmacobiodyn. 12:1989;341-344.